Hallucinogener

Psychedelic Research Papers
http://www.maps.org/resources/papers/
Can psychedelics have a role in psychiatry once again
http://bjp.rcpsych.org/content/186/6/457.full.pdf+html
A role for psychedelics in psychiatry?
http://bjp.rcpsych.org/content/187/5/483.2.full.pdf+html
Human Hallucinogen Research: Guidelines for Safety
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056407/pdf/nihms256719.pdf
Psychometric assessment of the Hallucinogen Rating Scale.
http://www.ncbi.nlm.nih.gov/pubmed/11295326
Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users.
http://www.ncbi.nlm.nih.gov/pubmed/22111402
Values and beliefs of psychedelic drug users: a cross-cultural study.
http://www.ncbi.nlm.nih.gov/pubmed/16903453
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
http://www.ncbi.nlm.nih.gov/pubmed/20717121
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.
http://www.ncbi.nlm.nih.gov/pubmed/21256140
The behavioral pharmacology of hallucinogens http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247373/pdf/nihms-37092.pdf
(2008) Is it time to revisit the role of psychedelic drugs in enhancing human creativity?
http://www.ncbi.nlm.nih.gov/pubmed/18562421
(2009) Cannabis and Ecstasy/ MDMA: empirical measures of creativity.
http://www.ncbi.nlm.nih.gov/pubmed/20235438


LSD 
Flashback: psychiatric experimentation with LSD in historical perspective.http://www.ncbi.nlm.nih.gov/pubmed/16086535

The pharmacology of lysergic acid diethylamide: a review.
http://www.ncbi.nlm.nih.gov/pubmed/19040555
Response of cluster headache to psilocybin and LSD.
http://www.ncbi.nlm.nih.gov/pubmed/16801660
(1989) LSD and creativity.
http://www.ncbi.nlm.nih.gov/pubmed/2723891
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of RCTs
http://jop.sagepub.com/content/early/2012/03/08/0269881112439253.full.pdf+html



Psilocybin
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050654/pdf/nihms252841.pdf
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
http://www.ncbi.nlm.nih.gov/pubmed/20819978
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
http://www.ncbi.nlm.nih.gov/pubmed/17196053
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
http://www.ncbi.nlm.nih.gov/pubmed/22308440
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors.
http://www.ncbi.nlm.nih.gov/pubmed/22578254


Ayahuasca / DMT 
A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.
http://www.ncbi.nlm.nih.gov/pubmed/22371425
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion.
http://www.ncbi.nlm.nih.gov/pubmed/21922603
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
http://www.ncbi.nlm.nih.gov/pubmed/17207120
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers.
http://www.ncbi.nlm.nih.gov/pubmed/11292011
Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.
http://www.ncbi.nlm.nih.gov/pubmed/21615005
A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life inayahuasca-naïve subjects.
http://www.ncbi.nlm.nih.gov/pubmed/19999673
Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
http://www.ncbi.nlm.nih.gov/pubmed/17532158
Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users.
http://www.ncbi.nlm.nih.gov/pubmed/20570058
Assessment of addiction severity among ritual users of ayahuasca.
http://www.ncbi.nlm.nih.gov/pubmed/20554400
Experiences of encounters with ayahuasca--"the vine of the soul".
http://www.ncbi.nlm.nih.gov/pubmed/20235436
Ayahuasca versus violence--a case report.
http://www.ncbi.nlm.nih.gov/pubmed/18959142
The globalization of ayahuasca: harm reduction or benefit maximization?
http://www.ncbi.nlm.nih.gov/pubmed/18638702


Salvia
Acute and post-acute behavioral and psychological effects of salvinorin A in humans.
http://www.ncbi.nlm.nih.gov/pubmed/21901316
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
http://www.ncbi.nlm.nih.gov/pubmed/21444610


4-HO-MET
Heaven and hell--a phenomenological study of recreational use of 4-HO-MET in Sweden.
http://www.ncbi.nlm.nih.gov/pubmed/22111404


Ketamin
Ketamine for treatment-resistant unipolar depression: current evidence.
http://www.ncbi.nlm.nih.gov/pubmed/22303887
Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. http://www.ncbi.nlm.nih.gov/pubmed/17523581
Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. http://www.ncbi.nlm.nih.gov/pubmed/12495789
Mood and Pain Responses to Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/22468772


DXM
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.
http://www.ncbi.nlm.nih.gov/pubmed/22526529